Online citations, reference lists, and bibliographies.
← Back to Search

Physicochemical Characterization Of Epigallocatechin Gallate Lipid Nanoparticles (EGCG-LNs) For Ocular Instillation.

J. Fangueiro, T. Andreani, L. Fernandes, M. García, M. Egea, A. M. Silva, E. Souto
Published 2014 · Medicine, Chemistry

Cite This
Download PDF
Analyze on Scholarcy
The encapsulation of epigallocatechin gallate (EGCG) in lipid nanoparticles (LNs) could be a suitable approach to avoid drug oxidation and epimerization, which are common processes that lead to low bioavailability of the drug limiting its therapeutic efficacy. The human health benefits of EGCG gained much interest in the pharmaceutical field, and so far there are no studies reporting its encapsulation in LNs. The purpose of this study has been the development of an innovative system for the ocular delivery of EGCG using LNs as carrier for the future treatment of several diseases, such as dry eye, age-related macular degeneration (AMD), glaucoma, diabetic retinopathy and macular oedema. LNs dispersions have been produced by multiple emulsion technique and previously optimized by a factorial design. In order to increase ocular retention time and mucoadhesion by electrostatic attraction, two distinct cationic lipids were used, namely, cetyltrimethylammonium bromide (CTAB) and dimethyldioctadecylammonium bromide (DDAB). EGCG has been successfully loaded in the LNs dispersions and the nanoparticles analysis over 30 days of storage time predicted a good physicochemical stability. The particles were found to be in the nanometer range (<300 nm) and all the evaluated parameters, namely pH, osmolarity and viscosity, were compatible to the ocular administration. The evaluation of the cationic lipid used was compared regarding physical and chemical parameters, lipid crystallization and polymorphism, and stability of dispersion during storage. The results show that different lipids lead to different characteristics mainly associated with the acyl chain composition, i.e. double lipid shows to have influence in the crystallization and stability. Despite the recorded differences between DTAB and DDAB, both cationic LNs seem to fit the parameters for ocular drug delivery.
This paper references
Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies.
C. Manach (2005)
Incorporation of the Model Drug Ubidecarenone into Solid Lipid Nanoparticles
H. Bunjes (2004)
Anti-inflammatory activity of lipophilic epigallocatechin gallate (EGCG) derivatives in LPS-stimulated murine macrophages.
Y. Zhong (2012)
Preparation and optimization of PIT solid lipid nanoparticles via statistical factorial design.
C. Carbone (2012)
Nanostructured lipid carriers for triamcinolone acetonide delivery to the posterior segment of the eye.
J. Araújo (2011)
Effect of Formulation Parameters on Corneal Permeability of Ofloxacin
M. Ahuja (2008)
Women's higher health risks in the obesogenic environment: a gender nutrition approach to metabolic dimorphism with predictive, preventive, and personalised medicine
N. Shapira (2012)
Effect of polymer viscosity on physicochemical properties and ocular tolerance of FB-loaded PLGA nanospheres.
J. Araújo (2009)
Tear film osmolarity: determination of a referent for dry eye diagnosis.
A. Tomlinson (2006)
Antiinflammatory Action of EGCG, the Main Component of Green Tea, through STAT‐1 Inhibition
E. Tedeschi (2002)
Particle Size Analysis in Pharmaceutics: Principles, Methods and Applications
Boris Y. Shekunov (2006)
Antimicrobial activity of the green tea polyphenol (-)-epigallocatechin-3-gallate (EGCG) against clinical isolates of Stenotrophomonas maltophilia.
Nicola C. Gordon (2010)
EGCG, a major green tea catechin suppresses breast tumor angiogenesis and growth via inhibiting the activation of HIF-1α and NFκB, and VEGF expression
J. Gu (2013)
Turbiscan lab expert analysis of the stability of ethosomes and ultradeformable liposomes containing a bilayer fluidizing agent.
C. Celia (2009)
Trypanosoma cruzi: in vitro and in vivo antiproliferative effects of epigallocatechin gallate (EGCg).
María C Güida (2007)
Solvent injection as a new approach for manufacturing lipid nanoparticles--evaluation of the method and process parameters.
M. Schubert (2003)
Bioavailability and bioefficacy of polyphenols in humans. II. Review of 93 intervention studies.
G. Williamson (2005)
Epigallocatechin-3-gallate inhibits angiotensin II and interleukin-6-induced C-reactive protein production in macrophages.
Ming Li (2012)
Solid lipid nanoparticles for ocular drug delivery
A. Seyfoddin (2010)
Epigallocatechin gallate (EGCG) attenuates high glucose-induced insulin signaling blockade in human hepG2 hepatoma cells.
Chih-Li Lin (2008)
Synergistic effects of (--)-epigallocatechin gallate with (--)-epicatechin, sulindac, or tamoxifen on cancer-preventive activity in the human lung cancer cell line PC-9.
M. Suganuma (1999)
Multifunctional effect of epigallocatechin-3-gallate (EGCG) in downregulation of gelatinase-A (MMP-2) in human breast cancer cell line MCF-7.
T. Sen (2009)
Evaluation of antioxidant activity of epigallocatechin gallate in biphasic model systems in vitro
C. Hu (2004)
Effect of light and temperature on zeta potential and physical stability in solid lipid nanoparticle (SLN) dispersions
C. Freitas (1998)
Regulation of interleukin-1β–induced chemokine production and matrix metalloproteinase 2 activation by epigallocatechin-3-gallate in rheumatoid arthritis synovial fibroblasts
S. Ahmed (2006)
Validation of a high performance liquid chromatography method for the stabilization of epigallocatechin gallate.
J. Fangueiro (2014)
Protective effects of epigallocatechin gallate (EGCG) derivatives on azoxymethane-induced colonic carcinogenesis in mice
Ying Zhong (2012)
An evaluation of osmolality measurement by freezing point depression using micro-amounts of sample
G. Koumantakis (1989)
Thermal Degradation Behavior of Polythiophene-modified Montmorillonite Nanocomposite
Amir Meguedad (2012)
Anti-inflammatory and anti-oxidative effects of the green tea polyphenol epigallocatechin gallate in human corneal epithelial cells
M. Cavet (2011)
Microspheres and nanoparticles used in ocular delivery systems
A. Zimmer (1995)
Neuroprotective molecular mechanisms of (−)-epigallocatechin-3-gallate: a reflective outcome of its antioxidant, iron chelating and neuritogenic properties
O. Weinreb (2009)
Thermodynamics of micellization of multiheaded single-chain cationic surfactants.
S. Bhattacharya (2004)
Nanomedicines for ocular NSAIDs: safety on drug delivery.
J. Araújo (2009)
Effect of light and temperature on zeta potential and physical stability in solid lipid nanoparticle ( SLNTM ) dispersions
R. H. Müller Freitas (1988)
Effect of cationic liposome composition on in vitro cytotoxicity and protective effect on carried DNA
R. Cortesi (1996)
(-)-Epigallocatechin-3-gallate suppresses osteoclast differentiation and ameliorates experimental arthritis in mice.
A. Morinobu (2008)
Epigallocatechin gallate prevents autoimmune diabetes induced by multiple low doses of streptozotocin in mice
Eun-Kyung Song (2003)
Solid Lipid Nanoparticles (SLN
E. Souto (2013)
Lipid nanoparticles: effect on bioavailability and pharmacokinetic changes.
E. Souto (2010)
Polyphenols: food sources and bioavailability.
C. Manach (2004)
Flavonoid antioxidants: chemistry, metabolism and structure-activity relationships.
Kelly E Heim (2002)
Encapsulation of polyphenols – a review
Zhongxiang Fang (2010)
Epigallocatechin-3-gallate increases the formation of mineralized bone nodules by human osteoblast-like cells.
B. Vali (2007)
Antioxidant and antiviral activities of lipophilic epigallocatechin gallate (EGCG) derivatives
Y. Zhong (2012)
The Synergistic Apoptotic Interaction of Panaxadiol and Epigallocatechin Gallate in Human Colorectal Cancer Cells
Guang-Jian Du (2013)
Cell signaling pathways in the neuroprotective actions of the green tea polyphenol (‐)‐epigallocatechin‐3‐gallate: implications for neurodegenerative diseases
S. Mandel (2004)
A novel lipid nanocarrier for insulin delivery: production, characterization and toxicity testing
J. Fangueiro (2013)
Characterization of lipid nanoparticles by differential scanning calorimetry, X-ray and neutron scattering.
H. Bunjes (2007)
Polysaccharides as Excipients for Ocular Topical Formulations
Y. Zambito (2011)
Physicochemical characterization of lipid nanoparticles and evaluation of their drug loading capacity and sustained release potential
K. Westesen (1997)
Lipophilised epigallocatechin gallate (EGCG) derivatives and their antioxidant potential in food and biological systems
Y. Zhong (2012)
Cancer chemoprevention with dietary phytochemicals
Young-Joon Surh (2003)
Cancer chemoprevention with dietary phytochemicals
Z. Dong (2003)
Hypoglycemic and hypolipidemic effect and antioxidant activity of chronic epigallocatechin-gallate in streptozotocin-diabetic rats.
M. Roghani (2010)
TURBISCAN MA 2000: multiple light scattering measurement for concentrated emulsion and suspension instability analysis.
O. Mengual (1999)
Epigallocatechin-3-gallate: a useful, effective and safe clinical approach for targeted prevention and individualised treatment of neurological diseases?
A. Mähler (2012)
Design of cationic lipid nanoparticles for ocular delivery: development, characterization and cytotoxicity.
J. Fangueiro (2014)
Polyphenols and disease risk in epidemiologic studies.
I. C. Arts (2005)
Green tea catechin intervention of reactive oxygen species-mediated ERK pathway activation and chronically induced breast cell carcinogenesis.
K. Rathore (2012)
Epigallocatechin-3-gallate (EGCG) enhances the therapeutic activity of a dental adhesive.
X. Du (2012)
Potential benefits of green tea polyphenol EGCG in the prevention and treatment of vascular inflammation in rheumatoid arthritis.
Sharayah Riegsecker (2013)
Bioavailability and antioxidant effect of epigallocatechin gallate administered in purified form versus as green tea extract in healthy individuals.
S. Henning (2005)

This paper is referenced by
Development of mucoadhesive and thermosensitive eyedrops to improve the ophthalmic bioavailability of ibuprofen
Hugo Almeida (2016)
Epigallocatechin-3-gallate loaded PEGylated-PLGA nanoparticles: A new anti-seizure strategy for temporal lobe epilepsy.
A. Cano (2018)
Green Tea Polyphenols as Potential Food Additives
Danxia Shi (2018)
Nanotechnology-Based Approach for Enhanced Bioavailability and Stability of Tea Polyphenols—A Review
Ravi Theaj Prakash Upputuri (2016)
Comparison of antiproliferative effect of epigallocatechin gallate when loaded into cationic solid lipid nanoparticles against different cell lines
A. M. Silva (2019)
Cationic Lipid Nanomedicines for the treatment of Diabetic retinopathy
J. Fangueiro (2015)
Preparation, characterization and biocompatibility studies of thermoresponsive eyedrops based on the combination of nanostructured lipid carriers (NLC) and the polymer Pluronic F-127 for controlled delivery of ibuprofen
H. Almeida (2017)
Designing lipid nanoparticles for topical ocular drug delivery.
J. Álvarez-Trabado (2017)
Supramolecular strategy of the encapsulation of low-molecular-weight food ingredients
L. Y. Zakharova (2016)
EGCG intestinal absorption and oral bioavailability enhancement using folic acid-functionalized nanostructured lipid carriers
Andreia Granja (2019)
The potential application of hyaluronic acid coated chitosan nanoparticles in ocular delivery of dexamethasone.
M. A. Kalam (2016)
Release kinetics and cell viability of ibuprofen nanocrystals produced by melt-emulsification.
A. R. Fernandes (2018)
Nanotargeted agents: an emerging therapeutic strategy for breast cancer.
Manling Du (2019)
Thermoresponsive sol-gel improves ocular bioavailability of Dipivefrin hydrochloride and potentially reduces the elevated intraocular pressure in vivo
Musaed Alkholief (2020)
Biopharmaceutical evaluation of epigallocatechin gallate-loaded cationic lipid nanoparticles (EGCG-LNs): In vivo, in vitro and ex vivo studies.
Joana F. Fangueiro (2016)
Employing a PLGA-TPGS based nanoparticle to improve the ocular delivery of Acyclovir
Musaed Alkholief (2019)
Combination delivery of two oxime‐loaded lipid nanoparticles: Time‐dependent additive action for prolonged rat brain protection
T. N. Pashirova (2018)
Perspectives on the recent developments with green tea polyphenols in drug discovery
Feng Li (2018)
Activity and controlled delivery of epigallocatechin 3-gallate in the treatment of degenerative disc disease
O. Krupkova (2016)
Cornea Therapeutic Efficacy of Nanocomplex of Poly ( Ethylene Glycol ) and Catechin for Dry Eye Disease in a Mouse Model
Hyesook Lee (2017)
Enhanced oral bioavailability of EGCG using pH-sensitive polymeric nanoparticles: characterization and in vivo investigation on nephrotic syndrome rats
Guojuan Zhang (2018)
Development of nanoencapsulated phenolic green extracts for functional food and nutraceutical: hibiscus sabdariffa as example
Sandra Pimentel Moral (2019)
Beyond liposomes: Recent advances on lipid based nanostructures for poorly soluble/poorly permeable drug delivery.
M. C. Teixeira (2017)
Poly (d, l-lactide-co-glycolide) nanoparticles for sustained release of tacrolimus in rabbit eyes.
M. A. Kalam (2017)
REVIEWS: CURRENT TOPICS Stability of ()-epigallocatechin gallate and its activity in liquid formulations and delivery systems
Olga Krupkova (2016)
Formulation and Characterization of Carvedilol Leciplex for Glaucoma Treatment: In-Vitro, Ex-Vivo and In-Vivo Study
Doaa H Hassan (2018)
Nanocarriers-encapsulating phytochemicals as potent therapeutics in cancer therapy
R. Radhakrishnan (2017)
Development of chitosan nanoparticles coated with hyaluronic acid for topical ocular delivery of dexamethasone.
M. A. Kalam (2016)
In Vitro Characterization, Modelling, and Antioxidant Properties of Polyphenon-60 from Green Tea in Eudragit S100-2 Chitosan Microspheres
E. B. Souto (2020)
Advances in nanobiomaterials for topical administrations: new galenic and cosmetic formulations
P. Severino (2016)
Self-assembly strategy for the design of soft nanocontainers with controlled properties
L. Y. Zakharova (2016)
Stability of (-)-epigallocatechin gallate and its activity in liquid formulations and delivery systems.
O. Krupkova (2016)
See more
Semantic Scholar Logo Some data provided by SemanticScholar